Detection of intracytoplasmic cytokine using flow cytometry and directly conjugated anti-cytokine antibodies. NLM AIDSLINE Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Detection of intracytoplasmic cytokine using flow cytometry and directly conjugated anti-cytokine antibodies.

J Immunol Methods. 1995 Dec 15;188(1):117-28. Unique Identifier : AIDSLINE MED/96140787
Prussin C; Metcalfe DD; Allergic Diseases Section, National Institute of Allergy and; Infectious Diseases, Bethesda, MD 20892-1888, USA.


Abstract: Recently, there have been several reports demonstrating improvements in the flow cytometric detection of intracellular cytokines. These advances, although significant, have not yielded techniques that have easily been translated into broad use. To address this issue, we have coupled a fixation and permeabilization method with the use of directly labelled monoclonal anti-cytokine antibodies, providing both improved signal and simpler staining. The kinetics of in situ cytokine production in both CD4 and CD8 cells are shown for IL-2, IL-4, IL-5 and IFN-gamma. Based on these data, 6 h was chosen for optimal detection of this combination of cytokines. We show the specificity of this technique by blocking cytokine staining using a molar excess of recombinant cytokine. Additionally, unlabelled anti-cytokine antibodies are demonstrated to block specific staining of labelled antibody, providing an objective means to place statistical markers. Using such controls, we routinely detected as few as 0.1% false positive cells, allowing the flow cytometric detection of IL-5, which is below the threshold of detection of published methods. To further prove the specificity of staining, we stained using two anti-IL-5 mAbs known to recognize different epitopes and demonstrate that the same cells stain with both antibodies. Without permeabilization we could detect a fraction of cells with low intensity staining for cytokine. This staining was further examined using differential two color staining for intracellular and extracellular cytokine, clearly demonstrating no cells staining exclusively for extracellular cytokine, confirming a lack of passive transfer of cytokine to nearby cells. We show that cytokine flow cytometry is useful in examining the increased IL-5 production characteristic of eosinophilic states and that IL-5 production is limited to the CD27 negative subpopulation. These data illustrate the unique capability of cytokine flow cytometry to correlate cytokine expression with cell surface phenotype without cell separation. In summary, using directly conjugated anti-cytokine antibodies, cytokine flow cytometry becomes a specific and versatile technique for the assessment of complex cytokine production phenotypes in fresh ex vivo T cell subpopulations.
Keywords: *Antibodies/PHARMACOLOGY Antibodies, Monoclonal/PHARMACOLOGY Antibody Specificity Binding Sites, Antibody Binding, Competitive/IMMUNOLOGY Cytokines/*ANALYSIS/*IMMUNOLOGY/PHARMACOLOGY Cytoplasm/*CHEMISTRY/IMMUNOLOGY CD4 Lymphocyte Count Eosinophilia/IMMUNOLOGY Flow Cytometry Fluorescent Antibody Technique, Direct Human Interleukin-5/ANALYSIS Kinetics Membrane Proteins/ANALYSIS Recombinant Proteins/PHARMACOLOGY JOURNAL ARTICLEKWDantibodies/pharmacologyantibodies,monoclonal/pharmacologyantibodyspecificitybindingsites,antibodybinding,competitive/immunologycytokines/KWDanalysis/KWDimmunology/pharmacologycytoplasm/KWDchemistry/immunologycd4lymphocytecounteosinophilia/immunologyflowcytometryfluorescentantibodytechnique,directhumaninterleukin-5/analysiskineticsmembraneproteins/analysisrecombinantproteins/pharmacologyjournalarticle
960430
M9640183

Copyright © 1996 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1996. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1996. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .